| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |